A Novel Approach to Safer Glucocorticoid Receptor-Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition.
Lesovaya EA, Savinkova AV, Morozova OV, Lylova ES, Zhidkova EM, Kulikov EP, Kirsanov KI, Klopot A, Baida G, Yakubovskaya MG, Gordon LI, Readhead B, Dudley JT, Budunova I.
Lesovaya EA, et al. Among authors: klopot a.
Mol Cancer Ther. 2020 Sep;19(9):1898-1908. doi: 10.1158/1535-7163.MCT-19-1111. Epub 2020 Jun 16.
Mol Cancer Ther. 2020.
PMID: 32546661
Free PMC article.